Imipenem/cilastatin AptaPharma 500 mg/500 mg prašak za otopinu za infuziju
| Name | Imipenem/cilastatin AptaPharma 500 mg/500 mg prašak za otopinu za infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-260156088 |
| Active Substance | imipenem hidrat cilastatinnatrij |
| Composition | jedna bočica sadrži imipenem hidrat što odgovara 500 mg imipenema i cilastatinnatrij što odgovara 500 mg cilastatina |
| Pharmaceutical Form | prašak za otopinu za infuziju |
| Manufacturer | ACS Dobfar S.p.A., Teramo, Italija |
| Marketing Authorisation Holder | Apta Medica Internacional d.o.o., Likozarjeva ulica 6, Ljubljana, Slovenija |
| Marketing Authorisation Date | 30.08.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/03 |
| Registration Number | 381-12-01/70-22-05 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J01DH51 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |